Zometa intravenous infusion 4mg/5mL, manufactured by Novartis Pharma, contains Zoledronic acid hydrate. This injectable drug, with YJ code 3999423A1044, is supplied as a 4mg/5mL single-dose vial for dilution, primarily used for hypercalcemia of malignancy and bone metastases.
Zometa intravenous infusion 4mg/5mL
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →